Unite d'Oncogenetique et de Prevention des Cancers
Welcome,         Profile    Billing    Logout  
 4 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Heinimann, Karl
DIALOGUE, NCT04214210: The Study: Swiss-Korean Billateral Collaboration

Recruiting
N/A
228
Europe
Adapted Family Gene Toolkit, Targeted intervention
University of Basel, Yonsei University, University Hospital, Basel, Switzerland, Hopital du Jura, Delemont, Switzerland, Department of Computer Science Yonsei University, Seoul, Korea, National Cancer Center, Korea, Chungnam National University, Ente Ospedaliero Cantonale, Ticino, Switzerland, Swiss National Science Foundation, Insel Gruppe AG, University Hospital Bern, University Hospital, Geneva
Hereditary Cancer, Breast Cancer, Ovarian Cancer
12/24
12/24
CASCADE, NCT03124212: Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

Recruiting
N/A
700
Europe
CASCADE genetic screening
University of Basel
Hereditary Breast and Ovarian Cancer, Lynch Syndrome
07/24
09/24
Chappuis, Pierre O
DIALOGUE, NCT04214210: The Study: Swiss-Korean Billateral Collaboration

Recruiting
N/A
228
Europe
Adapted Family Gene Toolkit, Targeted intervention
University of Basel, Yonsei University, University Hospital, Basel, Switzerland, Hopital du Jura, Delemont, Switzerland, Department of Computer Science Yonsei University, Seoul, Korea, National Cancer Center, Korea, Chungnam National University, Ente Ospedaliero Cantonale, Ticino, Switzerland, Swiss National Science Foundation, Insel Gruppe AG, University Hospital Bern, University Hospital, Geneva
Hereditary Cancer, Breast Cancer, Ovarian Cancer
12/24
12/24
CASCADE, NCT03124212: Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

Recruiting
N/A
700
Europe
CASCADE genetic screening
University of Basel
Hereditary Breast and Ovarian Cancer, Lynch Syndrome
07/24
09/24
Heinzelmann-Schwarz, Viola
MATAO, NCT04111978 / 2019-002264-27: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer

Recruiting
3
540
Europe
Letrozole 2.5mg, Femara, Placebo
Swiss GO Trial Group, AGO Study Group, Arbeitsgemeinschaft Gynaekologische Onkologie Austria, Reliable Cancer Therapies, Krebsliga Schweiz, Stiftung Guido Feger, Hoffmann-La Roche, Helsana AG, Novartis Pharmaceuticals, Anticancer Fund, Belgium
Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC), Low-grade Serous Ovarian Carcinoma (LGSOC), Ovarian Endometrioid Carcinoma
10/25
10/30
DIALOGUE, NCT04214210: The Study: Swiss-Korean Billateral Collaboration

Recruiting
N/A
228
Europe
Adapted Family Gene Toolkit, Targeted intervention
University of Basel, Yonsei University, University Hospital, Basel, Switzerland, Hopital du Jura, Delemont, Switzerland, Department of Computer Science Yonsei University, Seoul, Korea, National Cancer Center, Korea, Chungnam National University, Ente Ospedaliero Cantonale, Ticino, Switzerland, Swiss National Science Foundation, Insel Gruppe AG, University Hospital Bern, University Hospital, Geneva
Hereditary Cancer, Breast Cancer, Ovarian Cancer
12/24
12/24
CASCADE, NCT03124212: Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

Recruiting
N/A
700
Europe
CASCADE genetic screening
University of Basel
Hereditary Breast and Ovarian Cancer, Lynch Syndrome
07/24
09/24
OVPrecision, NCT06466382: OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

Not yet recruiting
N/A
60
Europe
Treatment recommendation by molecular tumorboard (mTB) based on tumor profiling, Carboplatin / Paclitaxel Chemotherapy, Standard of care chemotherapy regime
Swiss GO Trial Group, Tumor Profiler Center Switzerland
Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Ovarian Endometrioid Carcinoma, High-grade Serous Ovarian Carcinoma (HGSOC)
01/28
04/28
NCT04520672: Circulating Tumor Cells (CTC) in Cancer

Recruiting
N/A
3000
Europe
Blood samples, Samples from tumor draining vessels
University Hospital, Basel, Switzerland
Cancer
08/30
08/30

Download Options